Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 1.000 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.574 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.564 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.564 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.561 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.553 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.541 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.540 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.539 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.537 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.535 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.535 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.534 | |
4i0r | 1B4 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.533 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.532 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.532 | |
2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.532 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.531 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.529 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.527 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.526 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.526 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.525 | |
4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.525 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.525 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.524 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.524 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.524 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.522 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.521 | |
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.521 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.521 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.520 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.519 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.518 | |
3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.518 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.518 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.517 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.517 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.517 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.516 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.516 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.515 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.515 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.515 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.515 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.514 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.514 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.513 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.513 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.513 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.513 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.512 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.512 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.512 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.512 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.512 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.512 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.512 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.512 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.511 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.511 | |
2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.511 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.511 | |
3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.510 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.510 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.510 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.509 | |
3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.509 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.508 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.508 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.508 | |
4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.508 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.508 | |
5dt0 | SKE | Aurora kinase A | 2.7.11.1 | 0.508 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.507 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.507 | |
2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.506 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.506 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.506 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.506 | |
3wow | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.506 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.506 | |
4wbo | ANW | Rhodopsin kinase | / | 0.506 | |
5cu6 | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.506 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.505 | |
2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.505 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.505 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.505 | |
4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.505 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.504 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.504 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.504 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.504 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.504 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.503 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.503 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.503 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.502 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.502 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.502 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.502 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.502 | |
4jaj | XU1 | Aurora kinase A | 2.7.11.1 | 0.502 | |
5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.502 | |
2xru | 400 | Aurora kinase A | 2.7.11.1 | 0.501 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.501 | |
3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.501 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.501 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.501 | |
1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.500 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.500 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.500 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.500 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.500 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.500 | |
3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.500 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.500 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.500 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.500 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.500 | |
2q0b | ACP | Fibroblast growth factor receptor 2 | / | 0.499 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.499 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.499 | |
2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.498 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.498 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.497 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.497 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.497 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.497 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.497 | |
1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.496 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.496 | |
3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.496 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.496 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.496 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.496 | |
3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.495 | |
3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.495 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.495 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.495 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.495 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.494 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.494 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.494 | |
3rmf | 20Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.494 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.494 | |
4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.494 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.493 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.493 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.493 | |
2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.493 | |
3nga | 3NG | Casein kinase II subunit alpha | 2.7.11.1 | 0.493 | |
3t8o | ATP | Rhodopsin kinase | / | 0.493 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.493 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.493 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.493 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.492 | |
3uli | 1N3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.492 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.492 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.491 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.491 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.491 | |
4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.491 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.491 | |
4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 0.491 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.491 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.490 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.490 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.490 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.490 | |
4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.490 | |
4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.490 | |
4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.490 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.489 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.489 | |
2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.489 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
5dpv | SKE | Aurora kinase A | 2.7.11.1 | 0.489 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.488 | |
2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.488 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.488 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.488 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.488 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.488 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.488 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.487 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.487 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.487 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.487 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.487 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.487 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.487 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.486 | |
1ykr | 628 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.486 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.486 | |
3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.486 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.486 | |
3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.486 | |
4o0s | ADN | Aurora kinase A | 2.7.11.1 | 0.486 | |
1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.485 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.485 | |
2pyw | ADP | Methylthioribose kinase | 2.7.1.100 | 0.485 | |
3ral | 04Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.485 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
4f1s | F1S | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.485 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.485 | |
4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.485 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.484 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.484 | |
1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.484 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.484 | |
2x2k | X2K | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.484 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.484 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.484 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.484 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.484 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.484 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.484 | |
2pzr | ACP | Fibroblast growth factor receptor 2 | / | 0.483 | |
3bhh | 5CP | Calcium/calmodulin-dependent protein kinase type II subunit beta | 2.7.11.17 | 0.483 | |
3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.483 | |
4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.483 | |
1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.482 | |
1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.482 | |
2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.482 | |
3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.482 | |
4b7s | QLE | Cytochrome P450 monooxygenase PikC | / | 0.482 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.482 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
4mf1 | 29Y | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.482 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.482 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.481 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.481 | |
3bhy | 7CP | Death-associated protein kinase 3 | / | 0.481 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.481 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.481 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.481 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.481 | |
4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.481 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.481 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.480 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.480 | |
3v8t | 477 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.480 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.480 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.480 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.480 | |
1snu | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.479 | |
2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.479 | |
2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.479 | |
3at3 | ATK | Casein kinase II subunit alpha | 2.7.11.1 | 0.479 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.479 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.479 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.479 | |
4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
2pe0 | 39Z | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.478 | |
2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.478 | |
2zv2 | 609 | Calcium/calmodulin-dependent protein kinase kinase 2 | 2.7.11.17 | 0.478 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.478 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.478 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.478 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.477 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.477 | |
3vjn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.477 | |
4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.477 | |
4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.477 | |
4dea | NHI | Aurora kinase A | 2.7.11.1 | 0.477 | |
4kio | G5K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.477 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.477 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.477 | |
4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.477 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.476 | |
2a0c | CK9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.476 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.476 | |
4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.476 | |
4fz7 | 0VH | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.476 | |
4gii | 0X6 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.476 | |
4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.476 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.475 | |
2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.475 | |
3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
4f08 | 1RS | Tyrosine-protein kinase JAK2 | / | 0.475 | |
4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.475 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.475 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.475 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.474 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.474 | |
2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.474 | |
4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.474 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.473 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.473 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.473 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.473 | |
3axw | TID | Casein kinase II subunit alpha | 2.7.11.1 | 0.473 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.473 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.473 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.473 | |
4neu | Q1A | Receptor-interacting serine/threonine-protein kinase 1 | 2.7.11.1 | 0.473 | |
1cm8 | ANP | Mitogen-activated protein kinase 12 | / | 0.472 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.472 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.472 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.472 | |
3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
3dqw | AGS | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.472 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.472 | |
3roy | 22Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.472 | |
3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.472 | |
4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.472 | |
4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.472 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
4izy | 1J2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.472 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.472 | |
1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.471 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
1ke8 | LS4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.471 | |
2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.471 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.471 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.471 | |
3ezr | EZR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.471 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.471 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.471 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
4gj3 | 0XP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.471 | |
4jrn | ANP | Rhoptry kinase family protein | / | 0.471 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.471 | |
4w9w | YDJ | BMP-2-inducible protein kinase | 2.7.11.1 | 0.471 | |
1v1k | 3FP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.470 | |
3eb0 | DRK | Uncharacterized protein | / | 0.470 | |
3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.470 | |
3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.470 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.470 | |
3nup | 3NU | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.470 | |
3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.470 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.470 | |
5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.470 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.469 | |
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.469 | |
2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.469 | |
2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.469 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.469 | |
3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.469 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.469 | |
3w0s | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.469 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.469 | |
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.469 | |
4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.469 | |
4iva | 1J5 | Tyrosine-protein kinase JAK2 | / | 0.469 | |
5dr2 | ATP | Aurora kinase A | 2.7.11.1 | 0.469 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
1nxk | STU | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.468 | |
1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.468 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.468 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.468 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.468 | |
3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.468 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.468 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
4ckj | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.468 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.468 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.468 | |
1e3e | NAI | Alcohol dehydrogenase 4 | 1.1.1.1 | 0.467 | |
1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
1r78 | FMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.467 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.467 | |
3r7y | Z04 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
3r8l | Z30 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
3zmm | F9J | Tyrosine-protein kinase JAK2 | / | 0.467 | |
4fto | 3HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.467 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
2vtq | LZA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
3owk | 18E | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
3qzh | X69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
3w0p | ADP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.466 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.466 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.466 | |
5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.466 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.465 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.465 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.465 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.465 | |
2xng | A0H | Aurora kinase A | 2.7.11.1 | 0.465 | |
3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.465 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.465 | |
4b8l | A0P | Aurora kinase B-A | 2.7.11.1 | 0.465 | |
4dk5 | 0KO | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.465 | |
4fyo | 0VF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.465 | |
4fz6 | 0VG | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.465 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.465 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.464 | |
2cd8 | PXI | Cytochrome P450 monooxygenase PikC | / | 0.464 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.464 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.464 | |
3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.464 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.464 | |
3r7i | X9I | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3r7u | X96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.464 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
4hyh | 1AM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
4jay | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.464 | |
4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.464 | |
5eyp | LOC | Tubulin beta chain | / | 0.464 | |
1d2s | DHT | Sex hormone-binding globulin | / | 0.463 | |
2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.463 | |
3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.463 | |
4eol | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.463 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.463 | |
4lyn | 1YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.463 | |
1wvy | STU | Death-associated protein kinase 1 | 2.7.11.1 | 0.462 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.462 | |
2gdo | 12C | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.462 | |
2r3y | VAL_TYR_TRP_PHE | Serine endoprotease DegS | 3.4.21.107 | 0.462 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.462 | |
2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.462 | |
3f7z | 34O | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.462 | |
3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.462 | |
4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.462 | |
4ji9 | 1M3 | Tyrosine-protein kinase JAK2 | / | 0.462 | |
5auv | AGI | Death-associated protein kinase 1 | 2.7.11.1 | 0.462 | |
1rfv | ADP | Pyridoxal kinase | 2.7.1.35 | 0.461 | |
1wbp | ADP | SRSF protein kinase 1 | 2.7.11.1 | 0.461 | |
2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.461 | |
2x3n | FAD | Probable FAD-dependent monooxygenase | / | 0.461 | |
2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.461 | |
3b2t | M33 | Fibroblast growth factor receptor 2 | / | 0.461 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.461 | |
3sw7 | 19K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.461 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.461 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.461 | |
1qnf | FAD | Deoxyribodipyrimidine photo-lyase | 4.1.99.3 | 0.460 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.460 | |
2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.460 | |
2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
2w1e | L0E | Aurora kinase A | 2.7.11.1 | 0.460 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.460 | |
3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.460 | |
3qtr | X36 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.460 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
4y93 | 746 | Tyrosine-protein kinase | / | 0.460 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
5csh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.460 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
2pvm | P29 | Casein kinase II subunit alpha | 2.7.11.1 | 0.459 | |
2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.459 | |
3r1s | X73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.459 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.459 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.459 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.459 | |
4m15 | ADP | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.459 | |
2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2e9v | 85A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.458 | |
2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.458 | |
3bc3 | OPT | Cathepsin L1 | 3.4.22.15 | 0.458 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.458 | |
4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
4im2 | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.458 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
1uu9 | BI3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
2e9p | 77A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.457 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.457 | |
3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.457 | |
3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.457 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.457 | |
4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.457 | |
4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.457 | |
4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.457 | |
1fvt | 106 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
1h69 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.456 | |
1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.456 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.456 | |
2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.456 | |
2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.456 | |
3beg | ANP | SRSF protein kinase 1 | 2.7.11.1 | 0.456 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.456 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.456 | |
4d58 | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.456 | |
4gvj | ADP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.456 | |
4krc | AGS | Cyclin-dependent protein kinase PHO85 | 2.7.11.22 | 0.456 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
4xhg | ADP | Uncharacterized protein | / | 0.456 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.456 | |
5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.456 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
1ke7 | LS3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
1u5r | ATP | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.455 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.455 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
3sw4 | 18K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.455 | |
4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.455 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.455 | |
4otp | ADP | Serine/threonine-protein kinase RIO1 | 2.7.11.1 | 0.455 | |
4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.455 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.455 | |
1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2c6d | ANP | Aurora kinase A | 2.7.11.1 | 0.454 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.454 | |
2uze | C95 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2xmy | CDK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.454 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.454 | |
3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.454 | |
3lfs | A07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
3r8z | Z63 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
3sd0 | TSK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.454 | |
3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.454 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.454 | |
4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.454 | |
4dta | ADN | APH(2'')-Id | / | 0.454 | |
4hyi | 1AO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
4i4e | 1BQ | Focal adhesion kinase 1 | 2.7.10.2 | 0.454 | |
5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.454 | |
1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.453 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.453 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.453 | |
2pul | ACP | Methylthioribose kinase | 2.7.1.100 | 0.453 | |
2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.453 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.453 | |
3fzr | 3JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.453 | |
3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.453 | |
3w5p | 4OA | Vitamin D3 receptor | / | 0.453 | |
3zls | 92P | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.453 | |
4bcn | T9N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.453 | |
4ftq | 4HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.453 | |
4tv3 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.453 | |
1gy3 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
1ke5 | LS1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
1m2r | MNY | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.452 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.452 | |
2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.452 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.452 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.452 | |
3q5i | ANP | Protein kinase, putative | / | 0.452 | |
3qtu | X44 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.452 | |
4fkt | 48K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.452 | |
4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.452 | |
1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.451 | |
1urw | I1P | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
1z5m | LI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.451 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.451 | |
2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.451 | |
3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
3qzg | X67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3v3v | MYU | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.451 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.451 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
4ivb | 1J5 | Tyrosine-protein kinase JAK1 | / | 0.451 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.451 | |
4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.451 | |
4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.451 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.451 | |
1bws | NDP | GDP-L-fucose synthase | / | 0.450 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
1lhv | NOG | Sex hormone-binding globulin | / | 0.450 | |
1q4l | 679 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
1vyz | N5B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2c3q | GTX | Glutathione S-transferase theta-1 | 2.5.1.18 | 0.450 | |
2q7v | FAD | Thioredoxin reductase | / | 0.450 | |
2w17 | I19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.450 | |
3qts | X46 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
3t2z | FAD | Sulfide-quinone reductase | / | 0.450 | |
3w0n | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.450 | |
4acm | 7YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.450 | |
4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.450 | |
4ek6 | 10K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.450 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.450 | |
1hnc | GDN | Glutathione S-transferase Mu 2 | 2.5.1.18 | 0.449 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
2c5n | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.449 | |
2wmv | ZYV | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.449 | |
3cd5 | 7HI | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.449 | |
3dey | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.449 | |
3du8 | 553 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.449 | |
3klm | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.449 | |
3nuy | JPZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.449 | |
3qrt | X14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
3qtz | X42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
3zxt | ACP | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
4ezl | 0SE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.449 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.449 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.449 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.448 | |
1w0x | OLO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
2cgv | 3B3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
2np8 | CC3 | Aurora kinase A | 2.7.11.1 | 0.448 | |
2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
2wtj | WTJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.448 | |
2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.448 | |
3lq5 | SLQ | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.448 | |
3qxp | X64 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3vf9 | 477 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.448 | |
4b0g | VEK | Aurora kinase A | 2.7.11.1 | 0.448 | |
4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
4ewn | 0VR | Imidazole glycerol phosphate synthase subunit HisF | 4.1.3 | 0.448 | |
4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
4l8u | 9AZ | Serum albumin | / | 0.448 | |
4ylf | FAD | Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit homolog | / | 0.448 | |
1h1q | 2A6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.447 | |
2k5t | COA | PanD regulatory factor | / | 0.447 | |
2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2w06 | FRV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2wip | P49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2ym8 | YM8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
3qai | XNN | Ketohexokinase | / | 0.447 | |
3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.447 | |
4bie | IE6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.447 | |
4fkr | 45K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
1h66 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.446 | |
1om1 | IQA | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
1q99 | ANP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.446 | |
2a19 | ANP | Interferon-induced, double-stranded RNA-activated protein kinase | 2.7.11.1 | 0.446 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
2duv | 371 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
3qwk | X62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3s1c | ZIR | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.446 | |
3vew | ADP | nebramycin 5' synthase | 6.1.2.2 | 0.446 | |
4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
4eos | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.446 | |
4fki | 09K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.446 | |
4ix5 | ANP | Uncharacterized protein | / | 0.446 | |
4l7f | 1V5 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.446 | |
5av4 | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.446 | |
5ify | UMP | Glucose-1-phosphate thymidylyltransferase | / | 0.446 | |
5itz | LOC | Tubulin beta-2B chain | / | 0.446 | |
1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.445 | |
2vtj | LZ4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
2vto | LZ8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
2ydk | YDK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.445 | |
3opd | HIE | Heat shock protein 83 | / | 0.445 | |
3qc9 | ADP | Rhodopsin kinase | / | 0.445 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.445 | |
4a9s | RU9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.445 | |
4fsm | HK1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4ix6 | ADP | Uncharacterized protein | / | 0.445 | |
4pkl | 1GH | Uncharacterized protein | / | 0.445 | |
4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.445 | |
1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
2j9m | PY8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.444 | |
3ig7 | EFP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3nsz | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
3otu | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
3qcy | 3Q3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
3qtx | X43 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
4ccu | AWF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.444 | |
4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.444 | |
4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.444 | |
4g1z | 0VP | Vitamin D3 receptor A | / | 0.444 | |
4ogr | ADN | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.444 | |
4utd | ACP | Aurora kinase A | 2.7.11.1 | 0.444 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.443 | |
1ol5 | ADP | Aurora kinase A | 2.7.11.1 | 0.443 | |
1rkx | NAD | CDP-D-glucose-4,6-dehydratase | / | 0.443 | |
1uv5 | BRW | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
2b55 | D31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.443 | |
2fum | MIX | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.443 | |
2hcd | BIV | Vitamin D3 receptor A | / | 0.443 | |
2hyd | ADP | Putative multidrug export ATP-binding/permease protein SAV1866 | 3.6.3 | 0.443 | |
2pmo | HMD | Protein kinase 7 | / | 0.443 | |
2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.443 | |
3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
3fz1 | B98 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.443 | |
3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3r7v | Z02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.443 | |
4bgh | 3I6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.443 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
4fv8 | E63 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.443 | |
4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.443 | |
1gg5 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.442 | |
2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.442 | |
2i9p | NAD | 3-hydroxyisobutyrate dehydrogenase, mitochondrial | 1.1.1.31 | 0.442 | |
2wle | COA | Polysialic acid O-acetyltransferase | / | 0.442 | |
2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.442 | |
3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.442 | |
3lqf | NAD | Galactitol dehydrogenase | / | 0.442 | |
3umw | 596 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
4anw | O92 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
4jik | 1KO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.442 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.442 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
5eai | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.442 | |
1pxm | CK5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1xdd | AAY | Integrin alpha-L | / | 0.441 | |
2b7a | IZA | Tyrosine-protein kinase JAK2 | / | 0.441 | |
2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
2euf | LQQ | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.441 | |
2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.441 | |
2jkq | VG8 | Focal adhesion kinase 1 | 2.7.10.2 | 0.441 | |
2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.441 | |
2xuu | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.441 | |
3dfc | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.441 | |
3fpj | SAM | Uncharacterized protein | / | 0.441 | |
3own | 3OW | Renin | 3.4.23.15 | 0.441 | |
3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
3qxo | X65 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3rk5 | 07Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.441 | |
3w2e | NAD | NADH-cytochrome b5 reductase 3 | 1.6.2.2 | 0.441 | |
4fhi | 0S4 | Vitamin D3 receptor A | / | 0.441 | |
4fkq | 42K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
4fta | H5K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
4qi5 | FAD | Cellobiose dehydrogenase | / | 0.441 | |
5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.441 | |
2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
2izt | 23D | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.440 | |
2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.440 | |
2r3p | 3SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2uxp | CLM | HTH-type transcriptional regulator TtgR | / | 0.440 | |
2vti | LZ3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2xkf | BX1 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.440 | |
2yaa | ATP | Death-associated protein kinase 2 | / | 0.440 | |
3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.440 | |
3h9f | 92M | Dual specificity protein kinase TTK | 2.7.12.1 | 0.440 | |
3mnr | SD1 | Heat shock protein HSP 90-alpha | / | 0.440 | |
3qql | X03 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3qru | X19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.440 | |
3t1t | GDP | Probable gliding protein mglA | / | 0.440 | |
3vrw | YS5 | Vitamin D3 receptor | / | 0.440 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
4i0t | 1B6 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.440 | |
4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 | |
4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 | |
4mq2 | 2C4 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.440 | |
4r8q | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.440 | |
6cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 |